Smith nephew orthopedic products. How much does hip replacement cost and which implant is better to buy? POLARSTEM uncemented femoral stem

Smith Nephew hip endoprostheses have a wide range of products, allowing you to choose the right implant for each patient. These are high-quality and durable products with certified production technology and materials. Sold in many countries and recommended by doctors as a convenient, effective and safe means of replacing damaged joints.

Characteristics of Smith Nephew endoprostheses

Designed for the following functions:

  • relieve stress on the hip joint;
  • speed up the process of traditional therapy;
  • relieve pain syndrome;
  • restore limb mobility;
  • improve patient comfort;
  • stop the deformation and development of the disease.

Smith Nephew hip endoprostheses are created by leading manufacturers in this field. With their systematic wearing, the load on the injured joint is reduced and mobility is restored to the patient. Made from materials certified by a safety certificate, we constantly improve manufacturing technologies. They are mobile, highly durable and lightweight.

Range

POLARSTEM endoprosthesis from Smith & Nephew.

The femoral endoprosthesis from Smith & Nephew is produced in the following types:

  • OXINIUM;
  • XLPE;
  • Birmingham Hip;
  • LEGION;
  • ANTHOLOGY;
  • REDAP.

You should choose the type of endorotesis based on the doctor’s recommendations, and not the price of the product. All Smith Nephew products have quality certificates that must be checked before purchase.

Product OXINIUM

Made from an oxidized alloy of zirconium and niobium. It is more reliable and durable than cobalt-chromium alloy and is lighter. The development allows us to reduce the coefficient of friction and make it suitable for people who are allergic to nickel or hypersensitive to this material. The head, legs and swivels are made from the same material.

XLPE implant

The main material is cross-link polyethylene. It is produced through an irradiation process. It has medical confirmation that wear products are produced in smaller quantities. When combined with cobalt, knee and hip implants are called VERILAST. Recommended by doctors for patients with joint deformities.

SMF implant


Femoral head replacement with OXINIUM.

This is a short product that is 20% shorter in length than similar implants. Has a cementless installation core. Due to the successful shape, the bone tissue of the pelvis and hip is preserved and is less depleted. In this case, increased resection of the femoral neck may be allowed. After wearing an SMF prosthesis, the chance of having a more successful surgical operation increases.

Birmingham Hip

Used for superficial prosthetics of an injured joint. Because of this technology, the head of the femur is retained and does not require replacement with an implant due to grinding and enclosing the product in a shell. Patients wearing Birmingham Hip can safely perform loads of varying difficulty. It has a low risk of prolapse and a high rate of bone preservation. The material used to manufacture all parts is high-carbon cobalt-chromium-molybdenum alloy.

The Smith & Nephew company, founded in Great Britain, received its first major government order in 1914. And by the end of the 20th century, it became one of the largest suppliers of medical equipment and materials, and also became known for innovative developments in the field of orthopedics and endoscopy.

For hundreds of thousands of people around the world, endoprostheses from Smith & Nephew provide the opportunity to return to a full life, thanks to the constant improvement of technology and high-quality performance

Product Features

All endoprostheses are created from our own patented materials using advanced technologies, as well as software developed by the company.

OXINIUM

The material from which the heads, stems and acetabular implants are made is an oxidized alloy of zirconium (97.5%) and niobium (2.5%). It is 2 times more wear-resistant and stronger than cobalt-chromium alloy, and is also 20% lighter. The coefficient of friction is significantly reduced. Suitable for patients sensitive to nickel.

XLPE

Cross-link polyethylene. Obtained by irradiating standard polyethylene with a dose of 10 Mrad. The only one proven to produce fewer wear debris. For example, when testing a liner paired with cobalt chrome, the volume of wear particles decreased by 80% compared to conventional.

The combination of these materials used in the production of hip and knee implants is called VERILAST.

Hip endoprostheses

ANTHOLOGY

Minimally invasive endoprosthetic system for total hip replacement. Includes tool kit, head and stem with cementless installation. Designed for implantation through natural muscle gaps without damaging the muscles.

POLARSTEM uncemented femoral stem

Successfully used since 2002. The three-fold narrowing of the distal end, a self-locking design with a reinforced center allows you to reliably stabilize the implant. The shortened leg and narrowed shaft make it easy to install the prosthesis.

Suitable for insertion into the femur of any anatomical shape due to a wide selection of sizes, it reproduces the natural structure of the femur. Implantation is performed using a minimally invasive technique.

R3 Acetabular Prosthetic System

It consists of a cup and a liner that acts as a gasket between the head and the acetabulum. The dual mobility of the endoprosthesis is due to the sliding of the liner in the acetabulum and the head in the liner.

Advantages of the structure:

  • increasing primary stability;
  • anatomical nature of movement (up to 187 degrees) and minimal risk of dislocations (over 20 years, observation of 200 patients did not reveal a single dislocation).

Features of the R3 system:

  • the perfectly polished inner surface of the acetabular implant reduces reverse wear of the liner;
  • porous STIKTITE coating ensures stability.

The insert is available in two versions:

  • ceramic Made from medical materials BIOLOX forte (split strength 580 MPa) and BIOLOX delta (75% aluminum, 25% zirconium, higher mechanical properties), reinforced with a titanium ring;
  • polyethylene. They consist of polyethylene with cross-linked molecules - XLPE. Execution is standard and with a slope.

Restorative prosthesis REDAP

Cementless installation rod for total endoprosthetics. Advantages:

  • stability;
  • predictable fixation position.

One system for every revision surgery: the surgeon can tailor the rod to suit any clinical situation.

SMF leg

Cementless installation rod. 20% shorter than other implants, which significantly preserves bone tissue. Allows a higher level of resection of the femoral neck, which increases the chances of successful operations in the future.

Birmingham Hip prosthesis

With its help, surface hip replacement is performed. The essence of which is to preserve the patient’s own femoral head, which is ground down and enclosed in the implant shell. With such prosthetics, the joint can be subjected to almost any load, except for contact sports and heavy lifting. This method allows you to preserve much more bone tissue, the risk of loss is much lower.

The BHR consists of a cemented femoral head and an uncemented acetabular cup that forms the acetabulum. Both parts are composed of high-carbon cobalt-chromium-molybdenum alloy (CoCrMo). Which complies with ISO 5832 standard.

The outer surface of the spherical femoral head is perfectly polished. The inside of the sphere is hollow and fixed with polyacrylate cement. A rod protruding from the center of the sphere helps to achieve correct alignment relative to the axis of the femur.

The hemisphere-shaped acetabular cup has a hydroxyapatite coating on the outer side (contact with the bone), applied by plasma spraying for more effective healing with the patient’s bone tissue. The inner surface of the acetabular cup is perfectly smooth. Survival time is about 12 weeks. The element is installed using a tight fit method without cement.

Knee arthroplasty

Smith & Nephew artificial knees are lightweight, strong, flexible and durable. Considered one of the best in the world. JOURNEY II BCS three-piece prosthesis

The series includes implants for total knee replacement JOURNEY II BCS and II CR, as well as for partial replacement JOURNEY UNI and PFJ.

The endoprosthesis was modeled using our own innovative software (LifeModeler), thanks to which it reproduces natural movement as much as possible.

Advantages:

  • stabilization. Our own patented implant, which performs the functions of the anterior cruciate ligament, eliminates destabilization - the cause of repeated operations;
  • maximum possible knee flexion angle (up to 155°);
  • kinematics. The special anatomical shape of the condyles allows the bones in the knee joint to move naturally after surgery. While in a conventional joint replacement, the bones interact according to the principle of door hinges, which is far from anatomical.

Durability is ensured by a special OXINUM coating, as well as the use of XLPE polyethylene.

LEGION system


The LEGION line of three-piece implants includes models in the following configurations:

  • with a fixed disk;
  • restorative with a fixed disk;
  • restorative with a movable disk.

VERILAST technology is used in production. With offices in more than 80 countries, Smith & Nephew provides comprehensive warranty and information support for any of its products.

We innovate.
We work efficiently.
We gain trust.
We are Smith & Nephew.

Smith & Nephew is a multi-line health technology company supporting healthcare professionals to improve the quality of life for their patients.

We have about
16,000 employees
in more than 100 countries
Worldwide.


Orthopedic reconstruction Smith & Nephew has expertise in joint replacement systems for knees, hips and shoulders.

Traumatology For many years, Smith & Nephew has been producing high-quality traumatology products.

Sports medicine A wide range of instruments necessary to perform minimally invasive surgery.

Treatment of wounds Modern approaches to the treatment of household and postoperative wounds.

Our history


1856 Thomas James Smith opened a pharmacy in Hull, UK and developed a new method for purifying fish oil.


1896 Horace Nelson Smith partnered with his uncle, forming a company called Smith & Nephew.


1914 Shortly after the outbreak of the First World War we received an order for surgical and field dressings to supply the French Army. During the First World War the number of employees increased from 50 to 1,200.


2011 PICO™ is introduced, the first compact negative pressure system for wound care.


1986 Acquired the orthopedic company Ricards Medical Memphis, USA and the arthroscopic company Dyonics Andover, USA.


1977 OPSITE™ is introduced, the first dressing for the treatment of oozing wounds.


1937 We hit the London Stock Exchange.


2013 JOURNEY™ II BCS is introduced, setting a new standard for knee implants.


2014 Acquisition of ArthroCare, key to the development of our sports medicine business area.


Today We are proud of what we do and value the more than 14,000 employees who make it possible.

Why should you join us?

We are innovators striving for our goal Our entire organization works to expand access to advanced medical technologies and improve patient outcomes around the world. We've been doing this for over 150 years.

We value people with different experiences, backgrounds and ideas Our global program for respecting difference and individuality is designed to highlight the value of different ideas and perspectives in our work and personal relationships.
Understanding and appreciating these differences helps us better understand the diversity of cultures, customers and patients for whom we serve, better serve their needs and be a better company.


We're doing the right thing
even when no one is watching. We lead ethically and lead by example, embodying our values ​​and acting in accordance with our Code of Conduct.
All new employees who join our company receive a copy of our Code of Conduct and Business Principles and are retrained annually on the principles of the Code.

We consider skill
being innovative is extremely important At Smith & Nephew, we are all innovators - we challenge the status quo, innovate new solutions and strive to be the best at what we do for our clients.
We recognize that while few innovations will represent true breakthroughs, others will lead to equally important incremental changes.


We care about each other's well-being and the stability of Smith & Nephew We firmly believe that our people are our most important resource, and we take proactive steps to ensure that each of our employees is treated the way we would like to be treated ourselves. We treat the company's resources and the world's natural resources as if they were our own, and we are proud to maintain our position on the lists of significant and prestigious socially responsible investment and sustainability indices, including the Dow Jones Sustainability Index (DJSI) .

We value and encourage high results For us, the manner of action is as important as the action itself.
Our reward system concept is based on performance incentives. This means we reward employees for high performance, which helps deliver timely and tangible results that move the business forward. Our global employee recognition program, Going Extra, allows colleagues and managers to evaluate employee contributions based on our principles.


Benefits of working at Smith & Nephew

Smith&Nephew is a global corporation with 15,000 employees worldwide, specializing in the production of medical devices and dressings, with local offices in more than 100 countries.

Performance indicators

2018: Revenue growth by 3% to $4.9 billion

In 2018, Smith & Nephew earned $4.9 billion in revenue, up from $4.77 billion the year before.

The majority of the company's business continues to be in sports medicine and injury recovery products. In 2018, related activities brought Smith & Nephew a turnover of $2 billion, which is 4% more than a year ago. Revenues directly from sports medicine were $697 million, an increase of 11% compared to the previous year.

Technologies for arthroscopic surgery (minimally invasive surgical manipulation performed to diagnose and treat injuries to the inside of the joint) provided the company with revenue of $600 million versus $615 million in 2017.

From the financial report it follows that in 2018, Smith & Nephew bought 29 companies and spent about $1 billion on these acquisitions. The net debt of the American medical equipment manufacturer by December 31 dropped to $1.1 billion from $1.28 billion at the end of 2017.

Story

2019

Roland Diggelmann - CEO of Smith & Nephew

At the end of October 2019 the company Smith & Nephew, which develops and sells medical equipment, announced that Roland Diggelmann will become its new CEO as of November 1. Read more.

Purchase of camera developer for robotic surgeons Atracsys Sarl

In mid-June 2019, Smith & Nephew entered into an agreement to purchase the developer of cameras for robot surgeons Atracsys Sarl. Read more.

Purchase of Leaf Healthcare, a developer of equipment for the prevention of soft tissue necrosis

At the beginning of April, 2019 Smith & Nephew announced acquisition of the developer of the equipment for prevention of necrosis of soft tissues Leaf Healthcare. Read more.

Purchase of Brainlab division engaged in orthopedic joint reconstruction

On March 12, 2019, Smith & Nephew announced the purchase of a division of the company Brainlab, which specializes in orthopedic joint reconstruction. In addition, the companies have entered into an agreement to jointly develop additional applications for the enhanced automation platform. Read more.

Purchase of osteochondral implant manufacturer Osiris Therapeutics for $660 million

On March 12, 2019, Smith & Nephew announced the acquisition of osteochondral implant manufacturer Osiris Therapeutics for $660 million. Smith & Nephew announced that it would pay Osiris Therapeutics shareholders $19 of its own funds for each share they owned. Read more.

2018: Purchase of the developer of surgical instruments for meniscus repair Ceterix Orthopedics for $105 million

On December 18, 2018, Smith & Nephew announced the purchase of a developer of surgical instruments for meniscus repair

 

It might be useful to read: